642.44MUSD
0.06
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
AGP8696W1045
CUSIP
P8696W104
Sector
Biotechnology
Industry
Healthcare
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
6.66
PEG Ratio
-
Book Value
7.52
Dividend Share
-
Dividend Yield
0.00%
Earnings Share
0.971
Wall Street Target Price
6.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
510,624,000
Gross Profit TTM
443,444,000
EBITDA
219,500,000
Profit Margin
21.61%
Return On Assets TTM
11.46%
Return On Equity TTM
25.16%
Revenue Per Share TTM
5.163
Qtly Revenue Growth YOY
303.70%
Diluted Eps TTM
0.971
Qtly Earnings Growth YOY
354.80%
Trailing PE
6.66
Forward PE
0
Price Sales TTM
1.8306
Price Book MRQ
1.8161
Enterprise Value Revenue
0
Enterprise Value EBITDA
0
27.40
4.94%74.72
2.91%494.60
2.43%450.31
1.46%90.00
0.00%182.50
0.00%3.20
0.00%151.50
-4.36%108.54
-1.40%78.96
-0.15%